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Introduction.  The aim of this prospective study was to estimate the perception and popularity of complementary and al-
ternative medicine (CAM) subtypes and the reasons for usage among adult Polish cancer patients.
Material and methods.  The validated questionnaire was conducted among 310 patients. 24.1% of the patients used 
CAM during their oncological treatment. Risk factors for CAM usage were: female gender, university degree and radical 
treatment. The most common reasons for CAM usage were: boosting the immune system (46.1%), improving well-be-
ing/ counteracting the ill effects of cancer and its treatment (40.8%). The average level of satisfaction with CAM was high 
(≥3/5 on a Likert scale). Nearly half of the patients (46.6%) admitted not informing their doctors about their CAM usage.
Conclusions.  The growing popularity and heterogeneity of CAM methods make it an important issue for patient–doctor 
relations in Poland and other Central European countries. The results of this study indicate what topics should be covered 
while introducing patient education programs.
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Introduction
Over the last few decades, the treatment of cancer has im-
proved considerably. However, patients are constantly turning 
to methods that are not part of routine procedures. Comple-
mentary and alternative medicine (CAM) is a huge group of 
practices varying from alternative medical systems through 
mind-body interventions, biologically-based therapies, ma-
nipulation and body-based methods to energy “therapies”. 
According to the National Center for Complementary and Al-
ternative Medicine, it is “a group of diverse medical and health 
care systems, practices, and products that are not generally 
considered part of conventional medicine” [1] (tab. I).
Results obtained in numerous countries show that the 
range of CAM usage by cancer patients varies between 14.8% 
and 73.1% [2, 3]. These data were obtained before the CO-
VID-19 era and may be even higher now as during this period 
access to standard diagnostic and treatment procedures was 
limited, although results from Germany show similar statistics 
to those from pre-COVID-19 times [3]. There is also a shortage 
of current information about the application of CAM in Poland 
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and Central or Eastern Europe. It is important to estimate the 
popularity and perception of CAM among cancer patients in 
order to increase the awareness among physicians.
The aim of this study was to estimate the general perception 
of Polish cancer patients regarding CAM, its popularity, its types, 
and the reasons for its application. This research was also con-
ducted to check if the profile of patients using CAM in Poland is 
similar to other countries and if there is any correlation between 
medical or sociodemographic factors and the popularity of CAM.
To the best of our knowledge, our study has been the first 
concerning the usage of CAM in Central or Eastern Europe 
among the cancer patient population.
Material and methods  
Ethical approval 
The study was approved by Jagiellonian University Ethics Com-
mittee (Decision No. KBET/3/B/2012). The study was performed 
in accordance with the ethical standards laid down in the 1964 
Helsinki Declaration and its later amendments. All patients 
gave their written, informed consent to participate in the study. 
No conflict of interest was declared.
Building a tool
The questionnaire development process is describes in table II 
[4, 5]. We followed the European Organization for Research 
and Treatment of Cancer Quality of Life Group guidelines for 
questionnaire development with some changes concerning: 
single country cultural consistency and creating the initial ques-
tionnaire in Polish instead of English [4]. Data for the validation 
process were gathered between January 2012 and January 2013.
Study group
Inclusion and exclusion criteria
Patients’ inclusion criteria were: adult age (>18 years) and pri-
mary diagnosis confirmed by histopathological examination. 
There was no restriction as to the type of neoplastic disease 
or treatment type or intention. The exclusion criteria were: lack 
of informed consent to complete the questionnaire or refusal 
regarding accessing medical records. 
Data gathering
The validated survey was conducted as a personal interview 
among patients between February 2013 and January 2016, with 
both men and women, at the Department of Clinical Oncology, 
University Hospital in Krakow. The inpatients of the Oncological 
Ward and outpatients from the Ambulatory Chemotherapy 
Clinic were recruited. Interviewers assured them about confiden-
tiality before the interview started. In order to avoid concealment 
of information by the patients in the presence of their physicians, 
the interviewers were not involved in patients’ treatment. Pa-
tients were instructed on how to complete the questionnaire 
and were allowed to ask questions whenever any uncertainties 
arose. After completing questions about the sociodemographic 
data, the patients were asked if they had used CAM. All patients 
were asked a question about their perception of what CAM 
is and if it is approved by conventional medicine. If patients 
admitted using CAM, they were asked follow up questions. The 
whole procedure lasted 10–25 minutes, depending on whether 
the patient used CAM or not.
Data gathered from the questionnaires were supplemen-
ted by patients’ clinical records. Information acquired from 
patients’ histories included questions about: 
• type/intention of treatment (radical vs. palliative), 
• current treatment (chemotherapy vs. radiotherapy vs. ra-
diochemotherapy vs. hormonal therapy), 
• history of previous oncological treatment (yes/ what type 
of treatment vs. no), 
• date of diagnosis.
Table III shows the sociodemographic and medical data 
for 310 patients who completed the questionnaire.  
Statistical analysis
Statistical analysis was performed with the use of 
Statistica 10.0 PL (Statsoft). Elements of descriptive statistics 
Table I. The definition of the term “complementary and alternative medicine“ [1, 2] 
Complementary and alternative medicine
“the use of unproven interventions by individuals in conjunction with, or in place of, traditional or conventional means of treatment of various diseases or 
disease-related symptoms”
Complementary therapies Alternative therapies
“refers to using a non-mainstream approach together 
with conventional medicine”
“refers to using a non-mainstream approach in place of conventional medicine”
manipulation 
and body-based methods
movement therapies mind-body interventions biologically based 
therapies
alternative medical systems
• massage • yoga • meditation • herbs/herbal remedies • traditional Chinese medicine
• relaxation techniques • pilates • prayer • dietary supplements • ayurveda
• chiropractic • supportive groups • vitamins
• special diets
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were applied (mean, standard deviation, percentage distribu-
tion). The Student’s t-test was used when comparing quanti-
tative variables and the Mann–Whitney U test was applied in 
the absence of normal distribution of factors. The results of the 
univariate logistic regression were presented as odds ratios 
(OR) and 95% confidence intervals (95% CI). P-values of less 
than 0.05 were considered to indicate statistical significance.
Results
Over 24.1% of all patients used CAM during their oncological 
treatment. The mean age was 58.1 years (+/– 11.7 SD). CAM users 
were more often women (OR = 1.84; 95% CI: 1.07–3.13; p = 0.025) 
and had a university education (OR = 2.05; 95% CI: 1.18–3.57; 
p = 0.0107. Between CAM users and non-users, there were no 
differences as regards duration of the oncological treatment, 
the place of residence, marital status or age (p > 0.05). Patients 
during radical treatment tended to use more CAM than palliative 
patients (OR = 1.81; 95% CI: 1.07–3.07; p = 0.0277). Patients with 
breast cancer used CAM more often than patients with other 
types of malignancies (OR = 2.67; 95% CI: 1.38–5.16; p = 0.0036). 
Polish society is homogeneous – all patients from this stu-
dy were Polish citizens and Caucasian. Regardless of whether 
they were CAM users or non-users, all patients were asked 
a question about their definition of CAM. Table IV shows what 
their comprehension of the CAM term was. The higher the 
education level of patients (secondary and university educa-
tion) the better their knowledge of CAM (p < 0.0001). The term 
“Other” in table IV means patients’ own comments related to 
Table II. Actions taken to compile the questionnaire [4, 5]
Phases Action Description
Phase 1.  
Generation of 
issues
searching databases • Medline (1993–January 2012), Scopus and Up-To-Date databases were screened for all studies 
published in English concerning the use of CAM among adult oncological patients in Europe 
• the following keywords were used according to Boolean logic rules: complementary and alternative 
medicine, alternative medicine, alternative therapies, CAM, cancer, complementary therapies, Poland, 
neoplasm, oncology, patients, survey, questionnaire 
• the search strategy was developed specifically for each database
• the information was obtained initially from abstracts and then further complete papers
interviewing the 
patients
• the interviews with patients (n = 20; age range 18 to 72 years; 10 females and 10 males) were 
performed 
• the patients were asked to describe their experience concerning CAM and were permitted to 
provide information freely 
• the procedure was stopped when no new issue arose 
• discussing among health-care professionalsA list of 33 issues was generated and discussed among the authors of this study 
and a group of six other health-care professionals (two nurses, two medical students and two oncologists) 
• all assessed the relevance of each issue on the Likert scale (1 – not relevant at all, 5 – very relevant) and chose 15 issues for 
further consideration 
• the issue was selected if it achieved a mean score of 3.5 on the Likert scale and at least one-third of respondents prioritized 
the issue
• finally, one overlapping issue was deleted




generating a list of 
questions
• the chosen issues were used to build the items for the questionnaire 
• the provisional version consisted of 21 questions: eight about sociodemographic data and 13 about 
CAM compiled by the research team
• review by an expert
• review by an independent expert was performed






the provisional questionnaire was assessed 
by a group of five doctors, one nurse, one 
psychologist and five medical students 
• health-care professionals and patients found the 
questions easy to understand and acceptable
• confusing, upsetting or intrusive questions and 
issues were corrected (according to suggestions) 
after discussion between co-authors. E.g. 
question about earnings was deleted to avoid 
sensitive issues not directly pertaining to the 
study’s aim
testing on a group of 
patients
the provisional questionnaire was tested by 30 
patients at the Oncology Clinic (age range 41 to 




field-testing on a group 
of patients
• the final questionnaire developed for this study consisted of 19 items 
• questions were mostly closed-ended with an open answer category after a list of possible answers 
• questions were divided into three parts: sociodemographic data (six questions), usage and 
perception of the CAM term (two questions), and questions about CAM usage – only for patients 
who admitted usage of CAM (11 questions) 
• the main issues and most commonly used methods of CAM were specified. The number of 
respondents used for field-testing was 96 (age range 31 to 88 years; 55 females and 41 males)
• results for test-retest reliability with an assessment 2 weeks after the baseline by using interclass 
correlations showed a correlation from 0.8 to 0.92, which is considered excellent 
• in terms of construct validity, Cronbach’s alpha coefficient for the final questionnaire was 0.77. This 
value was considered acceptable 
final review of the 
questionnaire
• the questionnaire was accepted by the research team
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Table III. Sociodemographic and medical information about respondents
 
 
All participants CAM users Non-users
No. % No. % of all 
participants
No. % of all 
participants
sex women 161 51.9 48 15.5 113 36.5
men 149 48.1 28 9.0 121 39.0
age (years) 58.1 56.2 58.7
marital status single 23 7.4 7 30.4 16 69.6
married 240 77.4 56 23.3 184 76.7
widowed 34 11.0 11 32.4 23 67.6
divorced 12 3.9 2 16.7 10 83.3
place of living rural area 117 37.7 31 26.5 86 73.5
town/city of <20 000 inhabitants 25 8.1 6 24.0 19 76.0
town/city of 20 000–150 000 inhabitants 35 11.3 10 28.6 25 71.4
town/city of >150 000 inhabitants 133 42.9 29 21.8 104 78.2
education elementary 29 9.4 7 2.3 22 7.1
vocational 84 27.1 13 4.2 71 22.9
secondary 113 36.5 26 8.4 87 28.1
university 84 27.1 30 9.7 54 17.4
intention of 
treatment
radical 110 35.5 35 11.3 75 24.2
palliative 200 64.5 41 13.2 159 51.3
type of current 
treatment
chemotherapy 253 81.6 58 18.7 195 62.9
chemoradiotherapy 40 12.9 13 4.2 27 8.7
radiotherapy 3 1.0 2 0.6 1 0.3
hormonal therapy 13 4.2 3 1.0 10 3.2
type of 
treatment used 
in the past 
(more than one 
is possible)
chemotherapy 147 47.4 40 12.9 107 34.5
radiotherapy 82 26.5 21 6.8 61 19.7
surgery 237 76.5 64 20.6 173 55.8
other 16 5.2 6 1.9 10 3.2
no previous treatment 22 7.1 2 0.6 20 6.5
place of 
treatment
inpatient ward 227 73.2 54 17.4 173 55.8
outpatient clinic 83 26.8 22 7.1 61 19.8
type of cancer colorectal cancer 59 19.0 23 30.3 78 33.3
stomach cancer 59 19.0 10 13.2 49 20.9
breast cancer 45 14.5 19 25.0 26 11.1
lung cancer 17 5.5 1 1.3 16 6.8
head and neck cancer 13 4.2 4 5.3 9 3.8
pancreatic cancer 9 2.9 1 1.3 8 3.4
ovarian cancer 9 2.9 3 3.9 6 2.6
testicular cancer 7 2.3 2 2.6 5 2.1
others 51 16.5 20 6.5 53 17.1
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decisions about the usage of CAM, like: "My family and friends 
encouraged me to use it, and I trust them; I think that CAM is 
safe for my health; I wanted to try everything possible; I do not 
trust CAM or I think CAM is a mind therapy, not body therapy". 
Table V presents the prevalence of using particular CAM 
methods. Most patients had more trust in conventional me-
dicine (CM) (67.1%), but there was also a group of CAM users 
(17.1%) who trusted both CAM and CM the same way. Only 
2.6% (2 responders) trusted CAM more. The most commonly 
mentioned reason for using CAM was boosting the immune 
system (46.1%). Other popular arguments were: improving 
well-being/ counteracting the ill effects of cancer and its treat-
ment (40.8%); improving the prognosis (38.2%) and increasing 
the chance of recovery (28.9%). The most common source of 
information about CAM was family and friends (57.9%), over 
34.2% of CAM users employed some CAM methods before 
their oncological treatment. The amount of money spent each 
month on CAM was lower than 50 PLN (around 13 USD) for 
Table IV. Patients’ perception of the CAM term
All participants CAM users Non-users
No. % No. % No. %
What, in your 




they are methods that are moderately approved by 
conventional medicine (CM)
58 18.7 20 6.5 38 12.3
they are salutary methods unapproved by CM 39 12.6 11 0.0 28 0.1
they are methods that could be used instead of 
the CM
4 1.3 2 0.0 2 0.0
they are methods that could be used alongside CM 109 35.2 39 0.1 70 0.2
I do not have any opinion 101 32.6 14 0.0 87 0.3
other 70 22.6 10 0.0 60 0.2
Table V. Prevalence of CAM usage
Method CAM users
No. %
manipulation and body-based methods massage 3 3.9
relaxation techniques 2 2.6
movement therapies yoga 3 3.9
mind-body interventions prayer 24 31.6
psychotherapy/ support groups 6 7.9
biologically based therapies dietary supplements 31 40.8
herbal medicine 20 26.3










Ashkar method 0 0
folk/traditional medicine 0 0
other methods not listed above 20 26.3
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27.6% of respondents: 50–100 PLN for 25.0%. About 17.1% of 
CAM users spent 100–200 PLN monthly, 6.6% – 200–500 PLN 
and 7.9% more than 500 PLN. The most popular treatments 
mentioned by respondents were: 
• alkylglycerol (Ecomer, containing shark liver oil) (6.7% of 
CAM users), 
• specially prepared juices from vegetables or fruit (6.7%), 
• vitamin B17 – amygdalin (5.3%), 
• shark cartilage (5.3%), 
• noni juices (Morinda citrifolia) (5.3%), 
• extract from shiitake mushroom (Lentinula edodes) (4%), 
• extract from Polyporus betulinus nigricans (4%), 
• elements from Betula pendula (2.7%), 
• Graviola Immune (2.7%), 
• ayurweda (1.3%) and pilates (1.3%).
Discussion
CAM usage – the profile of users and potential 
reasons for CAM usage
Numerous researchers prove that CAM usage among cancer 
patients is higher than in the general population, but similar 
to patients with chronic diseases. Indeed, a recently published 
study regarding Polish patients with epilepsy showed similar 
percentages of CAM users in comparison to our population [6].
In this research, the profile of CAM users is the same as in 
many other research studies – patients with cancer using CAM 
tended to be female with higher education levels and were 
suffering from breast cancer. Better educated patients are 
probably more aware of their health status and show more 
interest in the process of their illness and treatment. CAM 
usage is connected with higher educational levels; in Israel, 
however, dietary supplement usage is more popular among 
people who are less formally educated. CAM can be seen as an 
active way to manage the disease, with some data suggesting 
that the intention of patients using CAM was to have a positive 
influence on their disease [7–10]. In this study, better educated 
patients seemed to have more ideas and reflections about 
CAM and they were probably more involved in the treatment 
of their disease. 4.5% of CAM users, in comparison to almost 
one third of non-users, did not have their own opinion about 
what CAM was. In Poland, the use of CAM was mainly affected 
by the influence of family and friends, while in the United 
Kingdom (UK), the Internet played a main role [11]. 
Alternative methods were nearly fifteen times more po-
pular among Polish patients than complementary ones, while 
in other studies this disparity is smaller – alternative methods 
are only three times more popular [12]. An explanation for this 
might be the different motivations for choosing CAM. In this 
research, the most popular reason for using CAM was “boosting 
the immune system” and diet supplements seem to be the 
most suitable and accessible way of achieving this. Huebner 
et al. (Germany) indicated the importance of “the reduction of 
side effects” and a “desire to become active” as equally impor-
tant, while Molassiotis et al. and other European researchers 
reported “increasing the body’s ability to fight cancer” as the 
most popular reason; complementary methods may more 
effectively fulfill these demands [13, 14]. Other reasons for the 
use of CAM by Polish patients were generally similar to those 
from other studies.
In Poland, patients during radical treatment tended to 
use CAM nearly twice as often as during palliative treatment, 
while other papers suggested that palliative patients, who 
have a poorer quality of life, are usually expected to use CAM 
more often. According to Eliott et al., palliative patients might 
be more depressive and hopeless and some of them might fail 
to continue to use CAM due to different practical and financial 
difficulties [15, 16]. Complementary methods like relaxation 
or psychotherapy might be especially favorable for palliative 
patients. However, in Poland there is little general awareness 
about these methods. During palliative oncological treatment, 
the spiritual needs of patients and the various problems asso-
ciated with the end of life should not be omitted or unnoticed. 
Unfortunately, in Poland the palliative treatment financed by 
the National Health Fund (NFZ) does not satisfy these demands. 
Moreover, overall psychological care in oncological and pallia-
tive departments is insufficient [17]. 
CAM methods used
Poland is a mainly Catholic country: 91.4% of the total popu-
lation (2018, http://stat.gov.pl/) belong to the Latin Church of 
the Roman Catholic Church. 24% of our participants claimed 
that they were praying for a cure. In this research, prayer was 
the second most common CAM among cancer patients, which 
is similar or less frequent to the outcomes from North Africa 
or Asia, while in Western Europe other methods were usually 
more popular [9, 18–20]. 
The profile of the method used in Poland is halfway between 
the profile from Western Europe or the USA and Asia. In Poland, 
like in Western countries and the USA, the most popular me-
thods were mainly various diet supplements (tab. V) [8, 9]. Diet 
supplements – regardless of their effectiveness – are the simplest 
methods that can be applied. They do not usually require major 
changes in lifestyle or involve much time, attention or effort. 
In Poland, methods like mind and body and relaxation 
techniques or acupuncture are still not very popular. In other 
European countries, relaxation is used by up to 32.4%, acu-
puncture up to 13% and spiritual methods up to 20.0%, while 
in our research it is only 7.8% for manipulation and body-ba-
sed methods (also including relaxation), 3.9% for movement 
therapies and 0% for acupuncture (tab. V). 
A systematic review from the USA names exercises, acu-
puncture and meditation, yoga, massage and music therapy 
among the most frequently mentioned on comprehensive 
cancer center websites. They are offered to cancer patients as 
commonly as dietary supplements and even more commonly 
than herbs [21–22]. According to Scott et al., in the UK, where 
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the average income is higher than in Poland, the most popular 
methods among cancer patients are relaxation, meditation 
and medicinal teas [12]. In Polish society these interventions 
are probably still regarded as “exclusive” and accessible only to 
younger people in bigger cities with higher incomes. In this 
study, participants were not asked about their income to avoid 
tactlessness, nevertheless the mean value of a salary in Poland 
in the first half of 2019 was 4951 PLN (1293 USD) (http://stat.
gov.pl). More expensive methods (like acupuncture or massa-
ge) are unaffordable for many patients in Poland. 
Moreover, in Poland and other countries from the Eastern 
Block (the former communist states of Central and Eastern 
Europe), common access to some methods, techniques and 
innovations was restricted for many years. 30 years ago this 
isolation ended, and the difficult and still ongoing reform 
of the health care sector began. It may still take many more 
years to overcome the challenges faced [23]. The mean age 
of this study population was 58.1 years which might suggest 
that many of the respondents might not be very familiar with 
the benefits of complementary therapies due to their age. 
Maybe the proportion of CAM types used will change over 
the coming decades. The last important factor is the fact that 
people living in smaller Polish cities or rural areas have limited 
access to some practices requiring professional staff (like yoga, 
pilates or support groups).
Safety and patient–doctor communication issues 
7.9% of our respondents claimed that using CAM delayed 
presenting oneself to a physician or oncologist with distur-
bing symptoms. This percentage is much lower than for the 
Asian population. A recently published retrospective study 
regarding a huge population (almost 2 000 000) of cancer 
patients concluded that CAM usage was associated with re-
fusal of standard treatment options and a higher risk of death. 
Earlier, Han et al. proved that CAM used as primary treatment 
for breast cancer increased the risk of progression, recurrence 
and death, however a study by Neuhouser et al. did not confirm 
this. Nevertheless, the risk of drug interactions when some of 
CAM methods are applied, in addition to standard oncological 
treatment, or even higher a risk of infections in some cases 
cannot be neglected [20, 24–27]. 
In our study, almost half the patients (46.57%) admitted not 
informing their doctors about CAM usage and this matches 
the results of the review by Davis et al. regarding the number 
of patients who do not disclose CAM usage (20–70%) [28]. 
Our patients point to their doctor’s lack of inquiry as to the 
main reason for nondisclosure, and this was also demonstra-
ted by other studies. It seems that patients lack the proper 
conversations about supportive methods for their oncolo-
gical treatment. Other studies reported similar results about 
patients’ fear of being judged by clinicians when sharing such 
information and their desire to be actively involved in their 
treatment [29–30]. 
Limitations of the study
The study has certain limitations, one of the biggest being the 
inequality of the groups – there were almost twice as many pal-
liative patients involved than radical and more inward patients 
than outward. The survey did not investigate the usage of vita-
min C infusions and this method was explored together with 
other methods as “dietary supplements”. Regarding the growing 
popularity of vitamin C infusions, this topic should be covered 
separately [10, 31]. An important influence on the proportion 
of women and men using CAM in our study was women with 
breast cancer – they accounted for 14.5% of all patients, but as 
many as 25.0% of all CAM users. Moreover, the response rate was 
not measured and the patients who did not give their consent to 
complete the questionnaire were not asked about their reason for 
refusal. The questionnaire needs a cross-cultural adaptation and 
a proper English translation in order to be used in other studies.
Conclusions
The study showed the differences between the USA,Western 
European and post-communist countries in terms of CAM 
usage in cancer patients. The profile of a Central European CAM 
user is also different from their Asian equivalent. Looking at 
the updated data from other regions, it can be assumed that 
Poland will also experience a shift in prevalence or types of 
CAM being commonly used.
The growing popularity and heterogeneity of CAM me-
thods make it an important issue for patient–doctor relations 
in Poland and other Central European countries. Oncologists 
and general practitioners in our region should start talking 
about CAM with their cancer patients. The results of this study 
indicate what topics should be covered while introducing 
patient education programs in Poland.
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